These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 32067258)

  • 1. Time for a New Slate in Tardive Dyskinesia Research.
    Blanchet PJ; Lévesque D
    Mov Disord; 2020 May; 35(5):752-755. PubMed ID: 32067258
    [No Abstract]   [Full Text] [Related]  

  • 2. Paliperidone Palmitate-Associated Severe Refractory Tardive Dyskinesia With Tardive Dystonia: Management and Six-Months Follow-Up.
    Singh S; Gupta A; Kuppili PP; Pattanayak RD; Khandelwal SK
    J Clin Psychopharmacol; 2016 Aug; 36(4):391-3. PubMed ID: 27269958
    [No Abstract]   [Full Text] [Related]  

  • 3. Cholinergic Medication for Antipsychotic-Induced Tardive Dyskinesia.
    Christie J
    Issues Ment Health Nurs; 2019 Dec; 40(12):1049-1050. PubMed ID: 31487207
    [No Abstract]   [Full Text] [Related]  

  • 4. [Tardive neuroleptic-induced dyskinesias].
    Zakharov DV; Buriak IV; Mihailov VA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(1):31-35. PubMed ID: 35175700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin E in the treatment of tardive dyskinesia: a meta-analysis.
    Xu H; Qin H; Chen S; Guan M
    Int Clin Psychopharmacol; 2022 Mar; 37(2):60-66. PubMed ID: 35045531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Withdrawal-Emergent Dyskinesia Related to Benztropine: A Case Report.
    Thalner S; Agrawal H
    WMJ; 2023 May; 122(2):143-145. PubMed ID: 37141483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case Report: Valbenazine as a Treatment for Tardive Dyskinesia and Unexpected Antipsychotic Effects.
    Khurram SK; Ames M; Muniz J
    J Clin Psychopharmacol; 2021 Mar-Apr 01; 41(2):220-221. PubMed ID: 33587391
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparing Treatments for Tardive Dyskinesia.
    Citrome LL
    J Clin Psychiatry; 2017; 78(9):e1429. PubMed ID: 29345877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valbenazine (Ingrezza) for tardive dyskinesia.
    Med Lett Drugs Ther; 2017 May; 59(1521):83-84. PubMed ID: 28520698
    [No Abstract]   [Full Text] [Related]  

  • 10. [Tardive dyskinesia in a child treated with atypical antipsychotics].
    Wittevrongel E; Vranken E; Pepermans A; Jaspers T
    Tijdschr Psychiatr; 2020; 62(10):901-905. PubMed ID: 33184822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Why Does Tardive Dyskinesia Have Oro-facial Predominance? A Network Analysis.
    Szalisznyó K; Silverstein DN
    Brain Topogr; 2023 Jan; 36(1):99-105. PubMed ID: 36592263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Late-Onset Dyskinesia Occurring During Antipsychotic Treatment for Schizophrenia: Management of Tardive Dyskinesia Based on the Latest Knowledge].
    Sakata M; Ito H
    Brain Nerve; 2022 May; 74(5):571-574. PubMed ID: 35589649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L-tryptophan in neuroleptic-induced tardive dyskinesia.
    Sandyk R; Bamford CR; Khan I; Fisher H
    Int J Neurosci; 1988 Sep; 42(1-2):127-30. PubMed ID: 2905343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Occurrence of tardive dyskinesia during neuroleptic treatment].
    Fanget F; Henry E; Aimard G
    Presse Med; 1986 Dec; 15(43):2147-50. PubMed ID: 2884657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative mechanisms and tardive dyskinesia.
    Lohr JB; Kuczenski R; Niculescu AB
    CNS Drugs; 2003; 17(1):47-62. PubMed ID: 12467492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antipsychotic-induced tardive syndromes].
    Fleischhacker WW; Hofer A; Jagsch C; Pirker W; Psota G; Rittmannsberger H; Seppi K
    Neuropsychiatr; 2016 Sep; 30(3):123-130. PubMed ID: 27580887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Managing antipsychotic-induced tardive dyskinesia.
    Gardos G
    Drug Saf; 1999 Feb; 20(2):187-93. PubMed ID: 10082074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient Trial Design - FDA Approval of Valbenazine for Tardive Dyskinesia.
    Davis MC; Miller BJ; Kalsi JK; Birkner T; Mathis MV
    N Engl J Med; 2017 Jun; 376(26):2503-2506. PubMed ID: 28489481
    [No Abstract]   [Full Text] [Related]  

  • 19. Tardive dyskinesia.
    Br Med J; 1979 Nov; 2(6201):1313. PubMed ID: 42473
    [No Abstract]   [Full Text] [Related]  

  • 20. Tardive dyskinesia and the long-term patient.
    Schwartz HJ
    Hosp Community Psychiatry; 1979 Jul; 30(7):465-7. PubMed ID: 36336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.